Kyntra Bio Inc (KYNB)

Jun 15, 2026

Kyntra Bio Inc. Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Revenue Biotech Advances PipelineLong-Term Guidance - newsline.com

Jun 15, 2026

Jun 13, 2026

Kyntra Bio Inc. (KYNB) Q1 2026 Earnings: EPS Misses Expectations, Shares Rally on Pipeline Progress - newsline.com

Jun 13, 2026

Jun 11, 2026

Kyntra Bio (KYNB) Reveals Positive Trial Results for Anemia Trea - GuruFocus

Jun 11, 2026

Jun 11, 2026

Kyntra Bio stock rises on roxadustat MDS trial data - Investing.com

Jun 11, 2026

Jun 11, 2026

Kyntra Bio stock rises on roxadustat MDS trial data By Investing.com - Investing.com Australia

Jun 11, 2026

Jun 11, 2026

Kyntra Bio presents roxadustat data for anemia in LR-MDS patients By Investing.com - Investing.com Australia

Jun 11, 2026

Jun 11, 2026

Kyntra Bio Presents New Roxadustat Data On Improvements In Patients With Anemia Due To Lower-Risk Myelodysplastic Syndromes - TradingView

Jun 11, 2026

Jun 11, 2026

Kyntra Bio presents roxadustat data for anemia in LR-MDS patients - Investing.com

Jun 11, 2026

Jun 11, 2026

Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes - The Manila Times

Jun 11, 2026

Jun 11, 2026

Kyntra Bio Presents New Roxadustat Data on Improvements in - GlobeNewswire

Jun 11, 2026

Jun 10, 2026

Kyntra Bio Receives Final $4 Million Payment Under 2025 Share Purchase Deal With AstraZeneca - Moomoo

Jun 10, 2026

Jun 09, 2026

Kyntra Bio Receives Final Payment for China Divestiture - TipRanks

Jun 09, 2026

Jun 09, 2026

Kyntra Bio (KYNB) CEO updates holdings after RSU tax-withholding event - Stock Titan

Jun 09, 2026

Jun 09, 2026

[Form 4] KYNTRA BIO, INC. Insider Trading Activity - Stock Titan

Jun 09, 2026

Jun 09, 2026

Kyntra Bio receives final $4.0M holdback from AstraZeneca, completes China sale proceeds - TradingView

Jun 09, 2026

Jun 09, 2026

Kyntra Bio (NASDAQ: FGEN) completes $220M China sale payments - Stock Titan

Jun 09, 2026

Jun 09, 2026

KYNB Initiated by Rodman & Renshaw -- Rating Set to Buy - GuruFocus

Jun 09, 2026

Jun 09, 2026

Rodman & Renshaw initiates Kyntra Bio stock with buy rating By Investing.com - Investing.com Nigeria

Jun 09, 2026

Jun 09, 2026

Rodman & Renshaw initiates Kyntra Bio stock with buy rating - Investing.com

Jun 09, 2026

Jun 06, 2026

Kyntra Bio Inc. (KYNB) Faces Selling Pressure as Stock Dips 1.47% – Key Levels in FocusFloat Adjusted Cap - newsline.com

Jun 06, 2026

Jun 05, 2026

KYNB Technical Analysis | Trend, Signals & Chart Patterns | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill

Jun 05, 2026

May 29, 2026

Kyntra Bio Inc. Q1 2026 Earnings: EPS Miss Amid Ongoing Pre-Revenue Development PhaseEarnings Manipulation Risk - newsline.com

May 29, 2026

May 27, 2026

Kyntra Bio Inc. Q1 2026 Earnings: Wider-Than-Expected Loss Reinforces Pre-Revenue ChallengesHigh Growth Earnings - The Legal Advocate

May 27, 2026

May 25, 2026

Kyntra Bio Inc. (KYNB) Q1 2026 Earnings: Wider-than-Expected Loss Amid Pre-Revenue R&D Push - The Legal Advocate

May 25, 2026

May 25, 2026

Kyntra Bio Inc. (KYNB) Q1 2026 Earnings: Wider-than-Expected Loss Fails to Dampen Investor SentimentProfit Margin Analysis - The Legal Advocate

May 25, 2026

May 23, 2026

Kyntra Bio Inc. (KYNB) Q1 2026 Earnings: Pre-Revenue Biotech Misses EPS Estimates as Stock Edges HigherEPS Growth Rate - The Legal Advocate

May 23, 2026

May 22, 2026

KYNB Stock Price, Quote & Chart | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill

May 22, 2026

May 20, 2026

Kyntra Bio CEO Thane Wettig buys $19,852 in stock - Investing.com India

May 20, 2026

May 19, 2026

Kyntra Bio CEO Thane Wettig buys $19,852 in stock By Investing.com - Investing.com Canada

May 19, 2026

May 19, 2026

KYNTRA BIO (KYNB) CEO Thane Wettig adds 2,800 shares in open-market buy - Stock Titan

May 19, 2026

May 19, 2026

What's Next for Kyntra Bio (KYNB) at $6.80? 2026-05-19Growth Picks - Newser

May 19, 2026

May 18, 2026

Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale - TipRanks

May 18, 2026

May 18, 2026

Kyntra Bio CEO Thane Wettig buys $19,852 in company stock By Investing.com - Investing.com Australia

May 18, 2026

May 18, 2026

Kyntra Bio CEO Thane Wettig buys $19,852 in company stock - Investing.com India

May 18, 2026

May 18, 2026

KYNTRA BIO (KYNB) CEO Thane Wettig purchases 2,800 shares at $7.09 - Stock Titan

May 18, 2026

May 15, 2026

Kyntra Bio (KYNB) Q1 2026 Earnings Transcript - AOL.com

May 15, 2026

May 15, 2026

Armistice Capital (FGEN) reports 400,000-share, 9.88% position (May 2026) - Stock Titan

May 15, 2026

May 15, 2026

Kyntra Bio (KYNB) Institutional Ownership 2026 - MarketBeat

May 15, 2026

May 14, 2026

Number of shareholders of Kyntra Bio, Inc. – NASDAQ:KYNB - TradingView

May 14, 2026

May 13, 2026

Number of shareholders of Kyntra Bio, Inc. – LSE:0IL8 - TradingView

May 13, 2026

May 12, 2026

Kyntra Bio (Nasdaq: KYNB) Q1 2026 results show higher revenue, ongoing R&D spend - Stock Titan

May 12, 2026

May 12, 2026

Kyntra Bio stock (US3156631046): Q1 2026 revenue rises to $3.7M amid pipeline advances - AD HOC NEWS

May 12, 2026

May 12, 2026

Kyntra Bio Inc. (KYNB) News, Articles, Events & Latest Updates - Stocktwits

May 12, 2026

May 12, 2026

Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances Amidst Challenges - GuruFocus

May 12, 2026

May 11, 2026

Kyntra Bio targets Q4 2026 interim readout while extending cash runway into 2028 - MSN

May 11, 2026